September 2026
The global aldose reductase inhibitor market size was evaluated at USD 7.24 billion in 2026 and is predicted to hit around USD 12.55 billion by 2035, growing at a CAGR of 6.30%.
September 2026
The global C5 complement inhibitors market size is estimated to hit around USD 17.83 billion by 2035 increasing from USD 5.54 billion in 2026, with a CAGR of 13.90%.
September 2026
The global VMAT2 inhibitors market size was evaluated at USD 6.62 billion in 2026 and is predicted to hit around USD 15.29 billion by 2035, growing at a CAGR of 9.74%.
September 2026
The global cell cycle inhibitors market size was evaluated at USD 6.13 billion in 2026 and is predicted to hit around USD 11.50 billion by 2035, growing at a CAGR of 7.23%.
September 2026
The global bone resorption inhibitors market size was evaluated at USD 4.13 billion in 2026 and is predicted to hit around USD 7.48 billion by 2035, growing at a CAGR of 6.82%.
September 2026
The global PD-1 inhibitor drugs market size was estimated at USD 56.29 billion in 2026 and is expected to hit around USD 201.87 billion by 2035, growing at a CAGR of 15.28% from 2026 to 2035.
September 2026
The SGLT-2 inhibitors market size was USD 19.31 billion in 2026, with leading SGLT-2 inhibitors market players including Boehringer Ingelheim, Eli Lilly and Company.
September 2026
The global calcineurin inhibitors market size was evaluated at USD 11.17 billion in 2026 and is predicted to hit around USD 20.88 billion by 2035, growing at a CAGR of 7.20%.
September 2026
The global clean label mold inhibitors market size reached USD 1.31 billion in 2026 and is projected to be worth around USD 2.24 billion by 2034, with a notable CAGR of 6.93%.
September 2026
The global checkpoint inhibitor biologics CDMO market is growing as demand rises for outsourced biologics development and scalable immuno-oncology manufacturing.
September 2026
The global paraffin inhibitors market size was valued at USD 773.59 million in 2026 and is projected to hit around USD 1,180.61 million by 2035, at a CAGR of 4.81%.
September 2026
The global immune checkpoint inhibitors market size is predicted to hit around USD 258.91 billion by 2035 from USD 68.13 billion in 2025 with a CAGR of 16.03%.
September 2026
The interleukin inhibitors market size was exhibited at USD 34.30 billion in 2026 and is expected to surpass around USD 93.68 billion by 2035 with a CAGR of 11.83%.
September 2026
The global enzyme inhibitor market size is estimated to hit around USD 45.72 billion by 2034 increasing from USD 30.02 billion in 2026, with a CAGR of 5.40%.
September 2026
The global corrosion inhibitors market size was estimated at USD 9.58Â billion in 2026 and is projected to surge around USD 13.34 billion by 2034, with a CAGR of 4.22%.
September 2026
The global lipase inhibitors obesity drugs market size was estimated at USD 1.65 billion in 2026 and is expected to hit around USD 4.94 billion by 2034, growing at a CAGR of 14.72%.
July 2026
The checkpoint inhibitor drugs market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries..
June 2026
The global leukemia inhibitory factor (LIF) market size is estimated to hit around USD 3.13 billion by 2035 increasing from USD 1.46 billion in 2026, with a CAGR of 8.85%.
April 2026
The global proton pump inhibitors market size is estimated to hit around USD 7.33 billion by 2035 increasing from USD 4.53 billion in 2026, with a CAGR of 5.50%.
July 2025
The global tumor necrosis factor inhibitor drugs market size is projected to hit around USD 51.55 billion by 2034 from USD 42.86 billion in 2024 with a CAGR of 1.86%.
January 2025
The global KRAS inhibitors market size is calculated at USD 118.26 million in 2025 and is projected to hit around USD 190.92 million by 2035 with a CAGR of 4.93%
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com